NCT01771822 - Ibuprofen 5% Topical Gel CIPT | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

January 31, 2013

Primary Completion Date

February 28, 2013

Study Completion Date

February 28, 2013

Conditions

Pain

Interventions

DRUG

Ibuprofen 5% topical gel

0.2 ml applied daily for 21 days over 3 weeks under occlusive conditions

DRUG

Topical gel vehicle

0.2 ml applied daily for 21 days over 3 weeks under occlusive conditions

DRUG

Sodium lauryl sulfate 0.2%

0.2 ml applied daily for 21 days over 3 weeks under occlusive conditions

DRUG

Sodium chloride solution 0.9% (saline)

0.2 ml applied daily for 21 days over 3 weeks under occlusive conditions

Trial Locations (1)

Pfizer Investigational Site, Carlstadt